is semaglutide in short supply Diabetes drug, gaining popularity for weight loss, RACGP - Do not initiate
Description
Less Progression to Stage 4 Disease in Some People Already Diagnosed With Cancer A study presented at the 2026 ASCO meeting looked at people with stage 1, 2, or 3 cancer who started either a GLP-1 drug or a DPP-4 inhibitor after diagnosis
Its complex mechanism of action makes it an effective tool for achieving and maintaining a healthy weight, as well as improving the general condition of the body

In a head-to-head comparison of the two GLP-1 drugs, adults living with obesity or overweight who were taking Zepbound, the brand name for tirzepatide, lost more than 20% of their weight on average after about a year and half, compared with an average of about 14% weight loss among those taking Wegovy, the brand name for semaglutide

Previous studies have demonstrated sustained improvements in cognitive and mood outcomes among exenatide-treated patients, with a significant 5.3-point advantage on the Mattis Dementia Rating Scale-2 (DRS-2

This article examines the current evidence, safety considerations, and appropriate clinical context for tirzepatide use in patients with Hashimoto's disease

So the accurate answer is "some muscle, but mostly fat, in a ratio similar to other GLP-1 drugs" not "retatrutide melts your muscle." What the Phase 2 Body-Composition Data Actually Shows Retatrutide's headline result is potency
